New federal price controls could hurt launch of new drugs

By The IJ Staff | February 04 2020 11:08AM

Photo: Unsplash

Ottawa’s new price controls for patented medicines in Canada are causing delayed product launches and a loss of jobs in the pharmaceutical industry, according to a survey of senior executives conducted for Life Sciences Ontario.

This article is reserved to PRO Level subscribers

Read the whole article….


$9.95 / month

Related to the same topic …